Qingdao Haier Biomedical Co Ltd688139
▲ PositiveCapitalrelevance
Company repurchased shares, signaling confidence and supporting stock price.

Haier Biomedical announced that as of July 31, 2026, the company had repurchased a total of 180,000 shares, accounting for 0.056% of total share capital, with a total repurchase amount of 5.01 million yuan and a repurchase price range of 28.15 yuan to 28.33 yuan per share. In addition, the company achieved revenue of 652 million yuan in the first quarter of 2026, with net profit attributable to the parent company of 79.46 million yuan.
Qingdao Haier Biomedical Co LtdCompany repurchased shares, signaling confidence and supporting stock price.